NEVVI Medicare utilization intelligence

← back

BATTS, ERICM.D. NPI 1821126830 Clinician

Hematology-Oncology · HOLLAND, MI

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF MICHIGAN MEDICAL SCHOOL — medical school, self-reported to CMS
In practice about 25 years since medical school (class of 2001, self-reported to CMS)
Location HOLLAND, MI · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 58 codes billed · 13,687 disclosed services (CY2024 — most recent year in data)
Current groups
member of 3 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-03

Year: 2024 · 2023 · 2022 locked column · 2021 locked column · 2020 locked column

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were premium in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services locked column Beneficiary-episodes locked column Avg charge locked column Avg Medicare payment locked column
J1100 Injection, dexamethasone sodium phosphate, 1 mg premiumpremium premiumpremium
36415 Insertion of needle into vein for collection of blood sample premiumpremium premiumpremium
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count premiumpremium premiumpremium
J2469 Injection, palonosetron hcl, 25 mcg premiumpremium premiumpremium
80053 Blood test, comprehensive group of blood chemicals premiumpremium premiumpremium
J9190 Injection, fluorouracil, 500 mg premiumpremium premiumpremium
96375 Injection of additional new drug or substance into vein premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
J9217 Leuprolide acetate (for depot suspension), 7.5 mg premiumpremium premiumpremium
96413 Administration of chemotherapy into vein, 1 hour or less premiumpremium premiumpremium
J3489 Injection, zoledronic acid, 1 mg premiumpremium premiumpremium
84153 Psa (prostate specific antigen) measurement, total premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
82784 Gammaglobulin (immune system protein) measurement premiumpremium premiumpremium
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services premiumpremium premiumpremium
83615 Lactate dehydrogenase (enzyme) level premiumpremium premiumpremium
96415 Administration of chemotherapy into vein, each additional hour premiumpremium premiumpremium
96417 Administration of additional new drug or substance into vein, 1 hour or less premiumpremium premiumpremium
83521 Measurement of immunoglobulin light chains premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle premiumpremium premiumpremium
82728 Ferritin (blood protein) level premiumpremium premiumpremium
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more premiumpremium premiumpremium
83735 Magnesium level premiumpremium premiumpremium
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less premiumpremium premiumpremium
J7030 Infusion, normal saline solution , 1000 cc premiumpremium premiumpremium
84443 Blood test, thyroid stimulating hormone (tsh) premiumpremium premiumpremium
96361 Infusion into a vein for hydration, each additional hour premiumpremium premiumpremium
84156 Total protein level, urine premiumpremium premiumpremium
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less premiumpremium premiumpremium
J1200 Injection, diphenhydramine hcl, up to 50 mg premiumpremium premiumpremium
96374 Injection of drug or substance into vein premiumpremium premiumpremium
96411 Administration of additional new drug or substance into vein using push technique premiumpremium premiumpremium
83540 Iron level premiumpremium premiumpremium
J3490 Unclassified drugs premiumpremium premiumpremium
84165 Protein measurement, serum premiumpremium premiumpremium
84100 Phosphate level premiumpremium premiumpremium
84466 Transferrin (iron binding protein) level premiumpremium premiumpremium
84403 Testosterone (hormone) level, total premiumpremium premiumpremium
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg premiumpremium premiumpremium
84550 Uric acid level, blood premiumpremium premiumpremium
96360 Infusion into a vein for hydration, 31-60 minutes premiumpremium premiumpremium
86704 Hepatitis b core antibody measurement premiumpremium premiumpremium
86706 Hepatitis b surface antibody measurement premiumpremium premiumpremium
87340 Detection test by immunoassay technique for hepatitis b surface antigen premiumpremium premiumpremium
82378 Carcinoembryonic antigen (cea) protein level premiumpremium premiumpremium
82607 Cyanocobalamin (vitamin b-12) level premiumpremium premiumpremium
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more premiumpremium premiumpremium
82746 Folic acid level, serum premiumpremium premiumpremium
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes premiumpremium premiumpremium
82565 Blood creatinine level premiumpremium premiumpremium
84439 Thyroxine (thyroid chemical), free premiumpremium premiumpremium
81000 Manual urinalysis test with examination using microscope, non-automated premiumpremium premiumpremium
96523 Irrigation of implanted venous access drug delivery device premiumpremium premiumpremium
36591 Collection of blood sample from implanted device premiumpremium premiumpremium
80061 Blood test, lipids (cholesterol and triglycerides) premiumpremium premiumpremium
82306 Vitamin d-3 level premiumpremium premiumpremium
80048 Blood test, basic group of blood chemicals (calcium, total) premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.